The effect of vitamin D3 on markers of oxidative stress in boys with X-linked ALD
维生素 D3 对 X 连锁 ALD 男孩氧化应激标志物的影响
基本信息
- 批准号:9293400
- 负责人:
- 金额:$ 18.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-06-15 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdrenal GlandsAdrenoleukodystrophyAffectAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsAreaAutoimmune ProcessBiologicalBiological MarkersBloodBrainCCL2 geneCaringCatabolismCell LineageCellsCerebrospinal FluidCerebrumChildCholecalciferolClinicalClinical ResearchClinical TrialsClinical/RadiologicColorComplicationDataDefectDemyelinating DiseasesDemyelinationsDiseaseDoseDrug KineticsEncephalitisEnrollmentFatty AcidsFlow CytometryFree RadicalsFutureGadoliniumGenesGeographic stateGlutathioneGoalsGrantHereditary DiseaseHistologicHumanIL8 geneImmuneImmunologic MarkersImmunologicsIncidenceIndividualInflammationInflammatoryInheritedInjuryInterleukin-1 betaK-Series Research Career ProgramsKnowledgeLeadLesionLeukocytesLifeLinkLipid PeroxidationLipid PeroxidesLipid-Laden MacrophageLipidsMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMass Spectrum AnalysisMeasuresMediator of activation proteinMentorsMetabolicMetabolismMethodsMolecular ProfilingMonitorMultiple SclerosisMultiple Sclerosis LesionsMyelinNADHNADPNeonatal ScreeningNeurodegenerative DisordersNeurologistOralOutcomeOxidation-ReductionOxidative StressOxidoreductaseParticipantPathogenesisPathologicPathway interactionsPatient CarePatientsPhenotypePositioning AttributePreventionPreventive therapyProductionProteinsResearch MethodologyResearch SupportRiskRoleSafetySerumSeverity of illnessSmall Interfering RNASupplementationTechniquesTissuesTrainingVery Long Chain Fatty AcidVitamin DVitamin D supplementationWagesWomanWorkagedbiobankboysbrain tissuecytokinefallshigh riskin vivoinsightinterestmacrophagemalemenmonocytemouse modelmultiple sclerosis patientneuroimmunologyneuroinflammationpatient orientedphase III trialpilot trialpreventpublic health relevanceresponsestandard of caretandem mass spectrometry
项目摘要
DESCRIPTION (provided by applicant): In this application for a Mentored Patient-Oriented Career Development Award, the candidate seeks 5 years of salary and research support to obtain further training and define the effect of vitamin D3 on markers of oxidative stress in boys with X-linked adrenoleukodystrophy (ALD; incidence 1:17,000). ALD is an inherited paroxysmal disease characterized by fatty acid accumulation and subsequent oxidative stress. Forty percent of ALD boys develop inflammatory cerebral demyelination (cerALD) in their first decade of life. Unfortunately, we have no means of identifying boys at risk for cerALD nor do we have any means of preventing the onset of cerebral ALD. These limitations represent enormous gaps in our standard of care for these patients. To address these limitations, the candidate and his collaborators consider the relationship of several key areas of current knowledge in cerALD: (1) ALD results from a peroxisomal gene defect that causes an accumulation of fatty acids which expose cells to lipid peroxides and other mediators of oxidative stress, (2) monocyte-lineage cells dominate the leading edge of the demyelinating lesions and (3) the lesions shares histologic features with multiple sclerosis lesions, a disease that has been linked to vitamin D insufficiency. Armed with this knowledge, the candidate has generated preliminary data showing that (1) low serum 25-OH vitamin D levels predict the onset of cerALD; (2) monocytes and brain myelin in ALD males have low glutathione levels compared to controls; (3) the spinal fluid from cerebral ALD boys shows a cytokine expression profile consistent with oxidative stress in monocyte-lineage cells; and lastly, (4) that oral vitamin D3 supplementation in a murine model of autoimmune demyelination significantly reduces clinical disease and increases intracellular glutathione levels in monocytes. The candidate proposes a pilot trial to study the effect of oral vitamin D3 supplementation on blood and brain biomarkers of oxidative stress in 20 ALD boys who have not yet developed cerebral ALD. In Aim 1 the candidate will use MRI techniques to monitor brain biomarkers of oxidative stress and inflammation in response to rising vitamin D levels. In Aim 2, the candidate will use 12-color flow cytometry and tandem mass spectrometry to study the effect of oral vitamin D3 supplementation on markers of oxidative stress in the specific immune cell subsets of study participants. In Aim 3, the candidate
will use bio banked ALD monocytes to define the metabolic and immunologic pathways linking vitamin D exposure with glutathione and cytokine modulation. The candidate's long term goal is to develop treatments and biomarkers for the prevention of cerebral ALD. The addition of ALD to universal newborn screening panels in an increasing number of US states bolsters the project's immediate relevance.
描述(由申请人提供):在这份以患者为导向的职业发展奖的申请中,候选人寻求 5 年的薪水和研究支持,以获得进一步的培训并确定维生素 D3 对 X 型男孩氧化应激标志物的影响相关性肾上腺脑白质营养不良(ALD;发病率为 1:17,000)是一种遗传性阵发性疾病,其特征是脂肪酸积累和随后的氧化应激。不幸的是,我们没有办法识别有患 cerALD 风险的男孩,也没有任何办法预防脑 ALD 的发生。为了解决这些患者的护理标准,候选人和他的合作者考虑了 cerALD 现有知识的几个关键领域的关系:(1)ALD 是由过氧化物酶体基因缺陷引起的,该缺陷会导致脂肪酸积累。将细胞暴露于脂质过氧化物和其他氧化应激介质中,(2) 单核细胞谱系细胞在脱髓鞘病变的前缘占主导地位,(3) 病变与多发性硬化症病变具有相同的组织学特征,多发性硬化症是一种与维生素 D 相关的疾病有了这些知识,候选人已经生成了初步数据,表明 (1) 血清 25-OH 维生素 D 水平低可预测 cerALD 的发生;(2) 单核细胞和大脑。与对照组相比,ALD 男性的髓磷脂具有较低的谷胱甘肽水平;(3) 脑 ALD 男孩的脊髓液显示出与单核细胞系细胞的氧化应激一致的细胞因子表达谱;(4) 口服维生素 D3 补充剂自身免疫性脱髓鞘的小鼠模型可显着减少临床疾病并增加单核细胞内谷胱甘肽水平。候选人提出一项试点试验,研究口服维生素 D3 补充剂对血液和大脑的影响。在目标 1 中,候选人将使用 MRI 技术来监测 20 名尚未发展为脑部 ALD 的男孩的氧化应激生物标志物,以应对维生素 D 水平升高的反应。使用 12 色流式细胞术和串联质谱法研究口服维生素 D3 补充剂对研究参与者特定免疫细胞亚群氧化应激标志物的影响。候选人
将使用生物库中的 ALD 单核细胞来确定维生素 D 暴露与谷胱甘肽和细胞因子调节之间的代谢和免疫途径,该候选人的长期目标是开发用于预防脑 ALD 的治疗方法和生物标志物。在美国越来越多的州,增强了该项目的直接相关性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Keith Van Haren其他文献
Keith Van Haren的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
内皮β3肾上腺素能受体调控线粒体功能参与血管衰老的作用研究
- 批准号:82370408
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
下丘脑-垂体-肾上腺轴在帕金森病抑郁中的作用及机制研究
- 批准号:82301597
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于APOE介导蓝斑去甲肾上腺素神经元损伤与Aβ-Tau蛋白交互协同作用诱导阿尔茨海默病神经退变机制的研究
- 批准号:82371999
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
去甲肾上腺素快速、特异性荧光探针构建及其抑郁模型原位成像
- 批准号:22377071
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于多模态PET/MR代谢脑网络探讨蓝斑-去甲肾上腺素系统参与认知老化的机制
- 批准号:82301789
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Dose Optimization of Nervonic Acid - a Potential Therapy to Alleviate Disease Progression in Adrenoleukodystrophy
神经酸的剂量优化——缓解肾上腺脑白质营养不良疾病进展的潜在疗法
- 批准号:
10436950 - 财政年份:2021
- 资助金额:
$ 18.58万 - 项目类别:
Dose Optimization of Nervonic Acid - a Potential Therapy to Alleviate Disease Progression in Adrenoleukodystrophy
神经酸的剂量优化——缓解肾上腺脑白质营养不良疾病进展的潜在疗法
- 批准号:
10184383 - 财政年份:2021
- 资助金额:
$ 18.58万 - 项目类别:
Revealing the Mechanisms and Physiology of Peroxisome Transfer in Stem Cell Therapy
揭示干细胞治疗中过氧化物酶体转移的机制和生理学
- 批准号:
9889194 - 财政年份:2019
- 资助金额:
$ 18.58万 - 项目类别:
NEWBORN SCREENING FOR PILOT STUDY FOR ADRENOLEUKODYSTROPHY (ALD)
新生儿肾上腺脑白质营养不良 (ALD) 试点研究筛查
- 批准号:
9360162 - 财政年份:2016
- 资助金额:
$ 18.58万 - 项目类别: